New review highlights FOXA2’s role in glucose regulation pathways
A newly published review highlights the pivotal role of FOXA2, a key transcription factor, in coordinating pancreatic development,…
Mouse study shows how liraglutide briefly rewires gut bacterial communities
A mouse study tracks how a leading GLP-1 drug alters gut bacteria over time, offering new clues to…
Ten-million-person study links semaglutide to lower COVID-19 mortality
After accounting for major health differences between semaglutide users and non-users, researchers identified a striking mortality association that…
Semaglutide and tirzepatide linked to fewer alcohol-related hospital visits
A large US health-record study suggests newer GLP-1 drugs may reduce alcohol-related acute-care visits, but the findings remain…
Semaglutide dose may matter more than weight loss for heart health
A large real-world study suggests semaglutide’s cardiovascular benefits may be more closely linked to the dose patients receive…
Gut microbiota may shape eating behavior and guide new obesity treatments
From appetite signals to food reward, researchers reveal how gut microbes may influence disordered eating and obesity, while…
GLP-1 medicines may cut clot-related risks in chronically inflamed patients
A large real-world analysis suggests GLP-1 receptor agonists may offer clot-related and survival benefits in a chronically inflamed,…
Justicia carnea extract alleviates oxidative stress in pancreatitis
Background and objectives Chronic pancreatitis is an inflammatory disease and is difficult to manage despite advancements in medical…
Scientists rethink GLP-1 delivery to improve dosing, tolerability, and adherence
From microneedles to nanocarriers, researchers are rethinking how GLP-1 medicines could become longer-lasting, easier to tolerate, and more…
People judge GLP-1 users more harshly than dieters
Even as GLP-1 medications transform obesity treatment, new research reveals a surprising reality: people may face stigma whether…
People judge weight loss more harshly when GLP-1 drugs are involved, study finds
Even when medication is paired with diet and exercise, people may still feel their weight loss is less…
GLP-1 drugs cut heart and kidney risks in type 1 diabetes study
A major real-world analysis suggests GLP-1 receptor agonists could offer heart, kidney, and weight benefits in type 1…